DCB-HDG2-57

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDCB-HDG2-57
Drug Alias Namedual mTOR-PI3 kinase inhibitor (Development Center for Biotechnology)DCB-HDG2-57
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSonic Hedgehog Homolog inhibitorsPI3-kinase class I inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsSonic Hedgehog HomologPI3-kinase class ISerine/threonine-protein kinase mTOR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDevelopment Center for Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDevelopment Center for Biotechnology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A